Datacubed Health is a technology company focused on making clinical trials more efficient.
Datacubed Health appointed Marc Eigner as executive chairman of the board. Eigner currently serves as an operating partner at the private equity group Berenson Capital.
Prior to joining Datacubed Health's board, Eigner co-founded Polaris, which was acquired by IQVIA in 2017.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.